TAIPEI, Dec. 12, 2024 /PRNewswire/ — VIVOTEK (3454-TW), the global leading security solution provider, continues to demonstrate exceptional capabilities by securing the 14th spot in the 2024 Security 50, remaining the only Taiwanese company in the top 20. This marks the company’s 12th consecutive year in this prestigious ranking.

VIVOTEK showcases its expertise in the security industry and has been increasingly committed to sustainable development in recent years. Through innovative technologies, it creates value and impact in the field of security. VIVOTEK showcases its expertise in the security industry and has been increasingly committed to sustainable development in recent years. Through innovative technologies, it creates value and impact in the field of security.

The Security 50, organized by a&s magazine (asmag.com), is one of the most respected rankings in the security industry. Since 2003, it has evaluated global leaders based on rigorous financial analysis, providing key insights for industry professionals and investors.

As it approaches its 25th anniversary, VIVOTEK continues to lead with AI-powered cameras, intelligent video management, and cloud services, leveraging its Taiwan-based R&D and manufacturing strengths to deliver a comprehensive security ecosystem amid growing demand for smart city and AI security solutions.

Source link

This content was prepared by our news partner, Cision PR Newswire. The opinions and the content published on this page are the author’s own and do not necessarily reflect the views of Siam News Network
You May Also Like

Agoda Highlights Bangkok, Singapore, and Seoul as 2024's Top Flight Destinations

SINGAPORE, Dec. 12, 2024 /PRNewswire/ — Digital travel platform Agoda unveils its list…

From Everyday Wins to Proud Parent Moments: Scott's Children's Day 2026 Goes #AnakSiapaNi

Launch of #AnakSiapaNi Anak Scott’s Lah campaign celebrating proud everyday moments when…

Mabwell Announces First Patient Dosed in Phase II Trial of Anti-IL-11 Antibody for Pathological Scarring

SHANGHAI, Dec. 30, 2025 /PRNewswire/ — Mabwell (688062.SH), an innovation-driven biopharmaceutical company…